Tipifarnib in the treatment of acute myeloid leukemia

por Thomas, Xavier, Elhamri, Mohamed
Publicado 2007

Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1

por Paubelle, Etienne, Plesa, Adriana, Hayette, Sandrine, Elhamri, Mohamed, Zylbersztejn, Florence, Hermine, Olivier, Salles, Gilles, Thomas, Xavier
Publicado 2019

Treatment with Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) with Acute Myeloid Leukemia: A Single Institution Experience

por Heiblig, Maël, Elhamri, Mohamed, Tigaud, Isabelle, Plesa, Adriana, Barraco, Fiorenza, Labussière, Hélène, Ducastelle, Sophie, Michallet, Mauricette, Nicolini, Franck, Plesa, Claudiu, Wattel, Eric, Salles, Gilles, Thomas, Xavier
Publicado 2016

Lyon-University Hospital Experience with Gemtuzumab Ozogamicin Therapy in Acute Myeloid Leukemia: a ‘Real-Life’ Study

por Laurino, Marica, Loron, Sandrine, Larcher, Marie-Virginie, Fossard, Gaëlle, Elhamri, Mohamed, Deloire, Alexandre, Balsat, Marie, Barraco, Fiorenza, Labussière, Hélène, Ducastelle, Sophie, Renault, Myriam, Wattel, Eric, Heiblig, Maël, Salles, Gilles, Thomas, Xavier
Publicado 2020

High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia

por Plesa, Adriana, Dumontet, Charles, Mattei, Eve, Tagoug, Ines, Hayette, Sandrine, Sujobert, Pierre, Tigaud, Isabelle, Pages, Marie Pierre, Chelghoum, Youcef, Baracco, Fiorenza, Labussierre, Helene, Ducastelle, Sophie, Paubelle, Etienne, Nicolini, Franck Emmanuel, Elhamri, Mohamed, Campos, Lydia, Plesa, Claudiu, Morisset, Stéphane, Salles, Gilles, Bertrand, Yves, Michallet, Mauricette, Thomas, Xavier
Publicado 2017